Jeffrey Lieberman, MD
Dr. Lieberman is a physician and scientist whose research has transformed our understanding and advanced the treatment of behavioral brain disorders and led to the transformative mental health care strategy for the early detection and prevention of schizophrenia.
Featured Books
Malady of the Mind: Schizophrenia and the Path to Prevention
In this rigorously researched, profoundly compelling biography of schizophrenia, renowned psychiatrist Dr. Jeffrey Lieberman draws on his four-decade career to illuminate the past, present, and future of this historically dreaded and devastating illness. This powerful portrait of schizophrenia, the most malignant and mysterious mental illness, interweaves cultural and scientific history with dramatic patient profiles and clinical experiences to impart a revolutionary message of hope. For the first time in history, we can effectively treat schizophrenia, limiting its disabling effects—and we’re on the verge of being able to prevent the disease’s onset entirely.
A must-read for fans of medical histories, psychology, and those whose lives have been affected by schizophrenia, this revelatory work offers a comprehensive scientific portrait, crucial insights, sound advice for families and friends, and most importantly, hope for sufferers now and in the generations to come.
Featured Press
Fast Company | Wall Street is embracing the psychedelic industry—and it’s causing a culture clash
Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction, and other mental health conditions. While psychedelics are still illegal under federal law, companies are […]
The People’s Pharmacy | Show 1373: Malady of the Mind
This week, our guest is one of the country’s leading experts on schizophrenia, Dr. Jeffrey Lieberman. He teaches at the Vagelos College of Physicians and Surgeons, part of Columbia University, where he studies the treatment of mental illness. His research […]
AP.com | As investors pile into psychedelics, idealism gives way to pharma economics
Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions. While psychedelics are still illegal under federal law, companies are jostling to try […]
Psychiatric Times | The Rx Crisis: The Impact of Ongoing ADHD Medication Shortages
Psychiatric Times • Aug 7 2023 According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD. Class […]
Fox News | How The Shortage of Prescription Stimulants Can Affect Students’ Return to SchoolFox News
Fox News • Sept 5 2023 Watch the latest video at foxnews.com
Healio | Atopic Dermatitis May Be Associated With Schizophrenia, Schizoaffective Disorder
By Richard Gawel | Perspective from Jeffrey A. Lieberman, MD | Perspective from Benjamin Ungar, MD | Fact checked by Kristen Dowd Atopic dermatitis was associated with increased odds of schizophrenia and schizoaffective disorder, according to a study published […]
Politico | We’re On The Cusp Of Another Psychedelic Era.
By ERIN SCHUMAKER and KATHERINE ELLEN FOLEY08/12/2023 07:00 AM EDT There’s a new cause in Washington that’s uniting Republicans, Democrats and Biden health officials: psychedelics as a cure for America’s mental health crisis. Long derided as counterculture party drugs, psychedelics […]
Healio | Despite Challenges, Mental Health Care Has Bright Outlook
In recognition of Mental Health Awareness Month, Jeffrey A. Lieberman, MD, highlighted several points about the field of mental health as it stands today. First, now is the best time in history for those with mental health disorders because the […]
